Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

New therapeutic agents for renal diseases in early development at Astellas Pharma

Sep. 8, 2005

Update on the potential of SVT-40776 as a novel treatment for overactive bladder

Sep. 7, 2005

GABA-B receptor agonists prepared and tested at Bayer

Sep. 1, 2005

Bayer claims novel vanilloid VR1 receptor antagonists for urological disorders

Aug. 25, 2005

Darifenacin improves quality of life of patients with overactive bladder

Aug. 18, 2005

Novel therapeutics for fibroproliferative diseases reported by Scios

Aug. 16, 2005

Clinical data confirm the efficacy of solifenacin in overactive bladder

Aug. 16, 2005

TH-070 begins phase III study for BPH

Aug. 10, 2005

Interim safety results of pivotal study of NX-1207 for BPH

Aug. 10, 2005

Phase IIb studies begin for PT-141 for erectile dysfunction

Aug. 9, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...